Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of platinum, pemetrexed, atezolizumab and bevacizumab combination in patients with advanced non-small cell lung cancer who have EGFR, ALK or ROS1 mutations and progressed after targeted therapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Ensartinib and Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer
Not recruiting
Investigated Drugs:
+3
Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy
Not recruiting
Investigated Drugs:
Study of BMS-986315 and Nivolumab with Chemotherapy for First-line Treatment in Stage IV or Recurrent Non-Small Cell Lung Cancer Patients
Not recruiting
Investigated Diseases:Investigated Drugs: